Cargando…
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591955/ https://www.ncbi.nlm.nih.gov/pubmed/31234810 http://dx.doi.org/10.1186/s12885-019-5831-x |
| _version_ | 1783429814746611712 |
|---|---|
| author | Perez, Edith A. de Haas, Sanne Lysbet Eiermann, Wolfgang Barrios, Carlos H. Toi, Masakazu Im, Young-Hyuck Conte, Pier Franco Martin, Miguel Pienkowski, Tadeusz Pivot, Xavier B. Burris, Howard A. Stanzel, Sven Patre, Monika Ellis, Paul Anthony |
| author_facet | Perez, Edith A. de Haas, Sanne Lysbet Eiermann, Wolfgang Barrios, Carlos H. Toi, Masakazu Im, Young-Hyuck Conte, Pier Franco Martin, Miguel Pienkowski, Tadeusz Pivot, Xavier B. Burris, Howard A. Stanzel, Sven Patre, Monika Ellis, Paul Anthony |
| author_sort | Perez, Edith A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6591955 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65919552019-07-08 Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer Perez, Edith A. de Haas, Sanne Lysbet Eiermann, Wolfgang Barrios, Carlos H. Toi, Masakazu Im, Young-Hyuck Conte, Pier Franco Martin, Miguel Pienkowski, Tadeusz Pivot, Xavier B. Burris, Howard A. Stanzel, Sven Patre, Monika Ellis, Paul Anthony BMC Cancer Correction BioMed Central 2019-06-24 /pmc/articles/PMC6591955/ /pubmed/31234810 http://dx.doi.org/10.1186/s12885-019-5831-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Perez, Edith A. de Haas, Sanne Lysbet Eiermann, Wolfgang Barrios, Carlos H. Toi, Masakazu Im, Young-Hyuck Conte, Pier Franco Martin, Miguel Pienkowski, Tadeusz Pivot, Xavier B. Burris, Howard A. Stanzel, Sven Patre, Monika Ellis, Paul Anthony Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer |
| title | Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer |
| title_full | Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer |
| title_fullStr | Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer |
| title_full_unstemmed | Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer |
| title_short | Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer |
| title_sort | correction to: relationship between tumor biomarkers and efficacy in marianne, a phase iii study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in her2-positive advanced breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591955/ https://www.ncbi.nlm.nih.gov/pubmed/31234810 http://dx.doi.org/10.1186/s12885-019-5831-x |
| work_keys_str_mv | AT perezeditha correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT dehaassannelysbet correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT eiermannwolfgang correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT barrioscarlosh correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT toimasakazu correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT imyounghyuck correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT contepierfranco correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT martinmiguel correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT pienkowskitadeusz correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT pivotxavierb correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT burrishowarda correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT stanzelsven correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT patremonika correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer AT ellispaulanthony correctiontorelationshipbetweentumorbiomarkersandefficacyinmarianneaphaseiiistudyoftrastuzumabemtansinepertuzumabversustrastuzumabplustaxaneinher2positiveadvancedbreastcancer |